Careers
Join the CellPort Team
Contact Us
We’re Streamlining Cell-Operations for All
Through next-gen platforms, assays, and protocols, CellPort prepares the life-sciences industry for its next, big breakthrough.
Through next-gen platforms, assays, and protocols, CellPort prepares the life-sciences industry for its next, big breakthrough.
By empowering the scientific community to safely and responsibly handle all aspects of cell-based operations, we hope to create a world where breakthroughs are made every single day.
Biomanufacturing & research labs today handle enormous amounts of information – managing materials, equipment, consumables, reagents, personnel, and more – when paper files and spreadsheets don’t cut it, the quality and quantity of production may suffer the consequences.
To overcome the growing complexity, CellPort was born in 2014 to bring next-gen capabilities to cell-based life sciences.
With the introduction of CellPort 3.0, we’ve added more customization features, like our Automated Workflow & Protocol Builder, enhanced Notes for in-depth observations and communication all in one place, and the new-and-improved Reporting tool for all your compliance requirements, like Master Batch Records (MBRs), FDA, GLP, GMP, and more – And there’s more features on the way.
Are you ready to achieve total control over your lab environment? At CellPort, we’re streamlining cell-manufacturing, so you can focus on the science.
The classic American entrepreneur story, Patrick Dentinger co-founded an analytical CRO in his attic in 1996. Over the coming decades, he transformed the organization into a world leader in testing for cell & gene therapies, then sold the company to Pharmaron in Nov. 2020.
All along the way, Mr. Dentinger dreamed of unlocking the power of cells. Through his vision & foresight, the company replaced paper lab notebooks by developing an in-house system for digitizing cell manufacturing – known as CellPort. After receiving overwhelmingly positive feedback from clients & regulators, Mr. Dentinger commercialized CellPort in 2021 to streamline cell-based operations for all.
As a veteran executive in the life-sciences industry, Gregory M. Banik brings years of experience leading digital transformations for Scientific, Technical, and Medical (STM) organizations – Dr. Banik’s expertise in customer-focused product development and strategic planning, along with his participation in scientific standard bodies, grants him the unique perspectives necessary to address the immediate needs of the technicians and researchers who use our SaaS platform on a daily basis, while keeping a long-term vision for future growth & development.
Get the latest industry news, product updates, and best practices in our monthly newsletter. Sign up and learn more about cell-based operations today!
